Amicus (FOLD) Hits 52-Week High on $5B BioMarin Merger
We recently published Ten companies in the spotlight. Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of Friday’s best performers. Amicus Therapeutics soared to a new 52-week high on Friday, jumping 30.21 percent to close at $14.18 apiece, as investors devoured shares following announcements that it would merge with Biomarin Pharmaceutical for nearly $5 billion. In intraday…